Literature DB >> 8383020

Gamma-aminobutyric acid and the liver.

G Y Minuk1.   

Abstract

Gamma-aminobutyric acid (GABA) is a potent amino acid neurotransmitter with various physiologic effects throughout the body. Over the past 40 years it has become evident that the mammalian liver contains high concentrations of GABA which are carefully regulated by a series of hepatic metabolic pathways and a specific sodium-dependent active transport system. It is also clear that the liver possesses sodium-independent, bicuculline-sensitive GABAA receptor sites which when innervated cause marked hyperpolarization of the hepatocyte transmembrane potential. Recent data suggest that extensive hepatic injury alters GABA homeostatic mechanisms which in turn may contribute to the pathogenesis of hepatic encephalopathy and systemic hypotension. There is also reason to believe that increased GABAergic activity may inhibit hepatic regeneration following partial hepatectomy in rats.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383020     DOI: 10.1159/000171400

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  11 in total

1.  An anti-coagulation agent Futhan preferentially targets GABA(A) receptors in lungepithelia: implication in treating asthma.

Authors:  Xuanmao Chen; Minghua Li; Zhi-Gang Xiong; Beverley A Orser; John F Macdonald; Wei-Yang Lu
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-15

Review 2.  Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas.

Authors:  George K Michalopoulos
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

3.  Gamma Amino Butyric Acid Attenuates Brain Oxidative Damage Associated with Insulin Alteration in Streptozotocin-Treated Rats.

Authors:  N A Eltahawy; H N Saada; A S Hammad
Journal:  Indian J Clin Biochem       Date:  2016-07-30

4.  After damage of large bile ducts by gamma-aminobutyric acid, small ducts replenish the biliary tree by amplification of calcium-dependent signaling and de novo acquisition of large cholangiocyte phenotypes.

Authors:  Romina Mancinelli; Antonio Franchitto; Eugenio Gaudio; Paolo Onori; Shannon Glaser; Heather Francis; Julie Venter; Sharon Demorrow; Guido Carpino; Shelley Kopriva; Mellanie White; Giammarco Fava; Domenico Alvaro; Gianfranco Alpini
Journal:  Am J Pathol       Date:  2010-02-25       Impact factor: 4.307

5.  G-Aminobutyric acid promotes methionine-choline deficient diet-induced nonalcoholic steatohepatitis.

Authors:  Seok Roh Yoon; Cho Ara; Zhou Zixiong; Jeong Hyuneui; Park Jeong-Eun; Cha Youn-Soo; Oh Suk-Heung; Lim Chae-Woong; Kim Bumseok
Journal:  J Biomed Res       Date:  2016-10-17

Review 6.  GABA and hepatocellular carcinoma.

Authors:  G Y Minuk
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

7.  Targeted metabolomic analysis identifies increased serum levels of GABA and branched chain amino acids in canine diabetes.

Authors:  Allison L O'Kell; Clive Wasserfall; Joy Guingab-Cagmat; Bobbie-Jo M Webb-Roberston; Mark A Atkinson; Timothy J Garrett
Journal:  Metabolomics       Date:  2021-11-14       Impact factor: 4.290

Review 8.  GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches.

Authors:  Stephanie Z Young; Angélique Bordey
Journal:  Physiology (Bethesda)       Date:  2009-06

9.  Synchronization by food access modifies the daily variations in expression and activity of liver GABA transaminase.

Authors:  Dalia De Ita-Pérez; Isabel Méndez; Olivia Vázquez-Martínez; Mónica Villalobos-Leal; Mauricio Díaz-Muñoz
Journal:  Biomed Res Int       Date:  2014-04-07       Impact factor: 3.411

10.  G-Aminobutyric acid promotes methionine-choline deficient diet-induced nonalcoholic steatohepatitis.

Authors:  Yoon Seok Roh; Ara Cho; Zixiong Zhou; Hyuneui Jeong; Jeong-Eun Park; Youn-Soo Cha; Suk-Heung Oh; Chae-Woong Lim; Bumseok Kim
Journal:  J Biomed Res       Date:  2016-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.